336 related articles for article (PubMed ID: 38124183)
1. Transcription factors in fibroblast plasticity and CAF heterogeneity.
Melchionna R; Trono P; Di Carlo A; Di Modugno F; Nisticò P
J Exp Clin Cancer Res; 2023 Dec; 42(1):347. PubMed ID: 38124183
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
3. Bioengineered Hydrogels Recapitulate Fibroblast Heterogeneity in Cancer.
Ho NCW; Yap JYY; Zhao Z; Wang Y; Fernando K; Li CH; Kwang XL; Quah HS; Arcinas C; Iyer NG; Fong ELS
Adv Sci (Weinh); 2024 May; 11(20):e2307129. PubMed ID: 38493497
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
[TBL] [Abstract][Full Text] [Related]
6. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.
Chen B; Chan WN; Xie F; Mui CW; Liu X; Cheung AHK; Lung RWM; Chow C; Zhang Z; Fang C; Yu P; Shi S; Zhou S; Chen G; Wang Z; Wang S; Ding X; Huang B; Liang L; Dong Y; Wong CC; Wu WKK; Cheng ASL; Wong N; Yu J; Lo KW; Tse GMK; Kang W; To KF
Clin Transl Med; 2023 Dec; 13(12):e1516. PubMed ID: 38148640
[TBL] [Abstract][Full Text] [Related]
7. Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance.
Galbo PM; Zang X; Zheng D
Clin Cancer Res; 2021 May; 27(9):2636-2647. PubMed ID: 33622705
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of cancer-associated fibroblast heterogeneity.
Kehrberg RJ; Bhyravbhatla N; Batra SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188901. PubMed ID: 37120098
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
10. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast heterogeneity in prostate carcinogenesis.
ChallaSivaKanaka S; Vickman RE; Kakarla M; Hayward SW; Franco OE
Cancer Lett; 2022 Jan; 525():76-83. PubMed ID: 34715252
[TBL] [Abstract][Full Text] [Related]
13. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.
Foster DS; Januszyk M; Delitto D; Yost KE; Griffin M; Guo J; Guardino N; Delitto AE; Chinta M; Burcham AR; Nguyen AT; Bauer-Rowe KE; Titan AL; Salhotra A; Jones RE; da Silva O; Lindsay HG; Berry CE; Chen K; Henn D; Mascharak S; Talbott HE; Kim A; Nosrati F; Sivaraj D; Ransom RC; Matthews M; Khan A; Wagh D; Coller J; Gurtner GC; Wan DC; Wapnir IL; Chang HY; Norton JA; Longaker MT
Cancer Cell; 2022 Nov; 40(11):1392-1406.e7. PubMed ID: 36270275
[TBL] [Abstract][Full Text] [Related]
14. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment.
Simon T; Salhia B
Mol Cancer Res; 2022 Feb; 20(2):183-192. PubMed ID: 34670861
[TBL] [Abstract][Full Text] [Related]
16. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.
Owen JS; Clayton A; Pearson HB
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671452
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment.
Ganguly D; Chandra R; Karalis J; Teke M; Aguilera T; Maddipati R; Wachsmann MB; Ghersi D; Siravegna G; Zeh HJ; Brekken R; Ting DT; Ligorio M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32957515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
